These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15576064)

  • 21. Perturbation of the Vacuolar ATPase: A NOVEL CONSEQUENCE OF INOSITOL DEPLETION.
    Deranieh RM; Shi Y; Tarsio M; Chen Y; McCaffery JM; Kane PM; Greenberg ML
    J Biol Chem; 2015 Nov; 290(46):27460-72. PubMed ID: 26324718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.
    Peng GS; Li G; Tzeng NS; Chen PS; Chuang DM; Hsu YD; Yang S; Hong JS
    Brain Res Mol Brain Res; 2005 Mar; 134(1):162-9. PubMed ID: 15790540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement.
    Gotfryd K; Owczarek S; Hoffmann K; Klementiev B; Nau H; Berezin V; Bock E; Walmod PS
    Neuropharmacology; 2007 Mar; 52(3):764-78. PubMed ID: 17095022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
    McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
    Neuroreport; 2007 Oct; 18(15):1595-8. PubMed ID: 17885608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of GluK2 kainate receptor expression by chronic treatment with mood-stabilizing anti-convulsants or lithium in cultured astrocytes and brain, but not in neurons.
    Li B; Zhang S; Li M; Zhang H; Hertz L; Peng L
    Neuropharmacology; 2009 Sep; 57(4):375-85. PubMed ID: 19596362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release.
    Ichikawa J; Chung YC; Dai J; Meltzer HY
    Brain Res; 2005 Aug; 1052(1):56-62. PubMed ID: 16061211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Di Daniel E; Mudge AW; Maycox PR
    Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic acid and CEBPalpha-mediated regulation of adipokine gene expression in hypothalamic neurons and 3T3-L1 adipocytes.
    Brown R; Imran SA; Ur E; Wilkinson M
    Neuroendocrinology; 2008; 88(1):25-34. PubMed ID: 18212493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drug.
    Sobol E; Yagen B; Steve White H; Wilcox KS; Lamb JG; Pappo O; Wlodarczyk BJ; Finnell RH; Bialer M
    Neuropharmacology; 2006 Sep; 51(4):933-46. PubMed ID: 16890251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
    Fukuchi M; Nii T; Ishimaru N; Minamino A; Hara D; Takasaki I; Tabuchi A; Tsuda M
    Neurosci Res; 2009 Sep; 65(1):35-43. PubMed ID: 19463867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MCK1 is a novel regulator of myo-inositol phosphate synthase (MIPS) that is required for inhibition of inositol synthesis by the mood stabilizer valproate.
    Yu W; Daniel J; Mehta D; Maddipati KR; Greenberg ML
    PLoS One; 2017; 12(8):e0182534. PubMed ID: 28817575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors.
    Montezinho LP; Mørk A; Duarte CB; Penschuck S; Geraldes CF; Castro MM
    Bipolar Disord; 2007 May; 9(3):290-7. PubMed ID: 17430304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
    Kurita M; Nishino S; Ohtomo K; Rai M; Shirakawa H; Mashiko H; Niwa S; Nakahata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):600-4. PubMed ID: 17258372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
    Löscher W; Nau H
    J Pharmacol Exp Ther; 1983 Sep; 226(3):845-54. PubMed ID: 6411902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of sodium valproate and its metabolites (5-OH-VPA and 4-OH-VPA) on electroconvulsions in rats.
    Sobaniec W; Sobaniec-Lotowska M
    Mater Med Pol; 1994; 26(1):29-32. PubMed ID: 7808038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T.
    McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
    Neuroreport; 2006 Aug; 17(12):1323-6. PubMed ID: 16951578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of rat prefrontal cortex after chronic valproate treatment.
    Thangavel M; Seelan RS; Lakshmanan J; Vadnal RE; Stagner JI; Parthasarathy LK; Casanova MF; El-Mallakh RS; Parthasarathy RN
    J Neurosci Res; 2014 Jul; 92(7):927-36. PubMed ID: 24692022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide.
    Sobol E; Yagen B; Lamb JG; White HS; Wlodarczyk BJ; Finnell RH; Bialer M
    Epilepsy Res; 2007 Jan; 73(1):75-84. PubMed ID: 16997532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis.
    Vaden DL; Ding D; Peterson B; Greenberg ML
    J Biol Chem; 2001 May; 276(18):15466-71. PubMed ID: 11278273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.